Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus

Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus

This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2024-06, Vol.331 (21), p.1799-1800
Hauptverfasser: Dawood, Fatimah S, Payne, Amanda B, McMorrow, Meredith L
Format: Artikel
Sprache:eng
Schlagworte:
Adults
Children
Effectiveness
Fatalities
Hospitalization
Illnesses
Immunization
Infants
Monoclonal antibodies
Older people
Populations
Prevention
Public health
Respiratory diseases
Respiratory syncytial virus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.
ISSN:0098-7484
1538-3598
1538-3598
DOI:10.1001/jama.2024.5859